Democratic Republic of Congo vs Congo: Hepatitis B surface antigen (HBsAg) prevalence (%)
Democratic Republic of Congo
1.4%
in 2024
Congo
1.6%
in 2024
Democratic Republic of Congo rank
19th
Congo rank
18th
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- Democratic Republic of Congo
- Congo
How they compare
Congo currently reports 1.6% against 1.4% in Democratic Republic of Congo, a difference of 0.2%.
That makes Congo's figure about 1.1 times Democratic Republic of Congo's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Democratic Republic of Congo ahead.
Democratic Republic of Congo ranks 19th and Congo ranks 18th of 194 countries.
Congo has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Democratic Republic of Congo | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.5% | 1.6% | 0.1% | Congo |
| 2020s | 1.4% | 1.6% | 0.2% | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Democratic Republic of Congo or Congo?
- Congo, at 1.6% against 1.4% in Democratic Republic of Congo as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Democratic Republic of Congo and Congo?
- 0.2%, with Congo ahead.
- How many years of comparable data are there for Democratic Republic of Congo and Congo?
- 10 years are reported by both, from 2015 to 2024.
- How do Democratic Republic of Congo and Congo rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Democratic Republic of Congo ranks 19th and Congo ranks 18th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.